Hopp til hovedinnhold

Livsstils- og miljøfaktorer ved MS

Sist oppdatert: Publisert:
  1. Backhaus I, Mannocci A, Lemmens PH, La Torre G. Smoking as a risk factor for developing Multiple Sclerosis: A meta-analysis of observational studies. Clin Ter. 2016 May-Jun;167(3):82-92. doi: 10.7417/CT.2016.1932. PMID: 27424509 PubMed  
  2. Heydarpour P, Manouchehrinia A, Beiki O, Mousavi SE, Abdolalizadeh A, -Lakeh MM, Sahraian MA. Smoking and worsening disability in multiple sclerosis: A meta-analysis. Acta Neurol Scand. 2018 Jul;138(1):62-69. doi: 10.1111/ane.12916. Epub 2018 Mar 15. PMID: 29542102. PubMed  
  3. Zivadinov R, Weinstock-Guttman B, Hashmi K, Abdelrahman N, Stosic M, Dwyer M, Hussein S, Durfee J, Ramanathan M. Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology. 2009 Aug 18;73(7):504-10. doi: 10.1212/WNL.0b013e3181b2a706. PMID: 19687451 PubMed  
  4. Degelman ML, Herman KM. Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation. Mult Scler Relat Disord. 2017 Oct;17:207-216. doi: 10.1016/j.msard.2017.07.020. Epub 2017 Jul 21. PMID: 29055459 PubMed  
  5. Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology. 2009 Sep 1;73(9):696-701. doi: 10.1212/WNL.0b013e3181b59c40. PMID: 19720976. PubMed  
  6. Hedström AK, Hillert J, Olsson T, Alfredsson L. Nicotine might have a protective effect in the etiology of multiple sclerosis. Mult Scler. 2013 Jul;19(8):1009-13. doi: 10.1177/1352458512471879. Epub 2013 Jan 14. PMID: 23319071. PubMed  
  7. Berg-Hansen P, Moen SM, Harbo HF, Celius EG. High prevalence and no latitude gradient of multiple sclerosis in Norway. Mult Scler. 2014 Nov;20(13):1780-2. doi: 10.1177/1352458514525871. Epub 2014 Mar 6. PMID: 24603884. PubMed  
  8. Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A. Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study. Neurology. 2017 Jan 3;88(1):44-51. doi: 10.1212/WNL.0000000000003454. Epub 2016 Nov 30. PMID: 27903815 PubMed  
  9. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 Dec 20;296(23):2832-8. doi: 10.1001/jama.296.23.2832. PMID: 17179460 PubMed  
  10. Munger KL, Åivo J, Hongell K, Soilu-Hänninen M, Surcel HM, Ascherio A. Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort. JAMA Neurol. 2016 May 1;73(5):515-9. doi: 10.1001/jamaneurol.2015.4800. PMID: 26953778 PubMed  
  11. Smolders J, Torkildsen Ø, Camu W, Holmøy T. An Update on Vitamin D and Disease Activity in Multiple Sclerosis. CNS Drugs. 2019 Dec;33(12):1187-1199. doi: 10.1007/s40263-019-00674-8. PMID: 31686407 PubMed  
  12. Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010 Aug;68(2):193-203. doi: 10.1002/ana.22043. PMID: 20695012. PubMed  
  13. Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol. 2012 Aug;72(2):234-40. doi: 10.1002/ana.23591. PMID: 22926855 PubMed  
  14. Hupperts R, Smolders J, Vieth R, Holmøy T, Marhardt K, Schluep M, Killestein J, Barkhof F, Beelke M, Grimaldi LME; SOLAR Study Group. Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a. Neurology. 2019 Nov 12;93(20):e1906-e1916. doi: 10.1212/WNL.0000000000008445. Epub 2019 Oct 8. PMID: 31594857 PubMed  
  15. Camu W, Lehert P, Pierrot-Deseilligny C, Hautecoeur P, Besserve A, Jean Deleglise AS, Payet M, Thouvenot E, Souberbielle JC. Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE). Neurol Neuroimmunol Neuroinflamm. 2019 Aug 6;6(5):e597. doi: 10.1212/NXI.0000000000000597. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2019 Nov 15;7(1): PMID: 31454777 PubMed  
  16. Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sørensen TI, Baker JL. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler. 2013 Sep;19(10):1323-9. doi: 10.1177/1352458513483889. Epub 2013 Apr 2. PMID: 23549432 PubMed  
  17. Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM. Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study. Mult Scler. 2015 Apr;21(4):388-95. doi: 10.1177/1352458514546785. Epub 2014 Sep 2. PMID: 25182290. PubMed  
  18. Jacobs BM, Noyce AJ, Giovannoni G, Dobson R. BMI and low vitamin D are causal factors for multiple sclerosis: A Mendelian Randomization study. Neurol Neuroimmunol Neuroinflamm. 2020 Jan 14;7(2):e662. doi: 10.1212/NXI.0000000000000662. PMID: 31937597 PubMed  
  19. Mowry EM, Azevedo CJ, McCulloch CE, Okuda DT, Lincoln RR, Waubant E, Hauser SL, Pelletier D. Body mass index, but not vitamin D status, is associated with brain volume change in MS. Neurology. 2018 Dec 11;91(24):e2256-e2264. doi: 10.1212/WNL.0000000000006644. Epub 2018 Nov 14. PMID: 30429274 PubMed  
  20. Oliveira SR, Simão AN, Kallaur AP, de Almeida ER, Morimoto HK, Lopes J, Dichi I, Kaimen-Maciel DR, Reiche EM. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress. Nutrition. 2014 Mar;30(3):268-73. doi: 10.1016/j.nut.2013.08.001. PMID: 24484677 PubMed  
  21. Castro K, Ntranos A, Amatruda M, Petracca M, Kosa P, Chen EY, Morstein J, Trauner D, Watson CT, Kiebish MA, Bielekova B, Inglese M, Katz Sand I, Casaccia P. Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course. EBioMedicine. 2019 May;43:392-410. doi: 10.1016/j.ebiom.2019.03.087. Epub 2019 Apr 10. PMID: 30981648 PubMed  
  22. Gupta S, Ahsan I, Mahfooz N, Abdelhamid N, Ramanathan M, Weinstock-Guttman B. Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions. CNS Drugs. 2014 Aug;28(8):731-42. doi: 10.1007/s40263-014-0173-3. PMID: 24871932. PubMed  
  23. Demay MB. The good and the bad of vitamin D inactivation. J Clin Invest. 2018 Aug 31;128(9):3736-3738. doi: 10.1172/JCI122046. Epub 2018 Aug 6. PMID: 30080183 PubMed  
  24. Bruyère O, Cavalier E, Souberbielle JC, Bischoff-Ferrari HA, Beaudart C, Buckinx F, Reginster JY, Rizzoli R. Effects of vitamin D in the elderly population: current status and perspectives. Arch Public Health. 2014 Sep 28;72(1):32. doi: 10.1186/2049-3258-72-32. PMID: 25279143 PubMed  
  25. Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT. High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial. BMC Neurol. 2017 Apr 4;17(1):67. doi: 10.1186/s12883-017-0851-0. PMID: 28376767 PubMed  
  26. Steffensen LH, Jørgensen L, Straume B, Mellgren SI, Kampman MT. Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol. 2011 Sep;258(9):1624-31. doi: 10.1007/s00415-011-5980-6. Epub 2011 Mar 13. PMID: 21400196 PubMed  
  27. Razazian N, Kazeminia M, Moayedi H, Daneshkhah A, Shohaimi S, Mohammadi M, Jalali R, Salari N. The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurol. 2020 Mar 13;20(1):93. doi: 10.1186/s12883-020-01654-y. PMID: 32169035. PubMed  
  28. Motl RW, Gosney JL. Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis. Mult Scler. 2008 Jan;14(1):129-35. doi: 10.1177/1352458507080464. Epub 2007 Sep 19. PMID: 17881388. PubMed  
  29. Latimer-Cheung AE, Pilutti LA, Hicks AL, Martin Ginis KA, Fenuta AM, MacKibbon KA, Motl RW. Effects of exercise training on fitness, mobility, fatigue, and health-related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development. Arch Phys Med Rehabil. 2013 Sep;94(9):1800-1828.e3. doi: 10.1016/j.apmr.2013.04.020. Epub 2013 May 10. PMID: 23669008. PubMed  
  30. Paltamaa J, Sjögren T, Peurala SH, Heinonen A. Effects of physiotherapy interventions on balance in multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials. J Rehabil Med. 2012 Oct;44(10):811-23. doi: 10.2340/16501977-1047. PMID: 22990349. PubMed  
  31. Charron S, McKay KA, Tremlett H. Physical activity and disability outcomes in multiple sclerosis: A systematic review (2011-2016). Mult Scler Relat Disord. 2018 Feb;20:169-177. doi: 10.1016/j.msard.2018.01.021. Epub 2018 Feb 2. PMID: 29414293. PubMed  
  32. Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K. Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study. Mult Scler. 2018 Feb;24(2):150-157. doi: 10.1177/1352458517694088. Epub 2017 Feb 1. PMID: 28273774. PubMed  
  33. Kalb R, Brown TR, Coote S, Costello K, Dalgas U, Garmon E, Giesser B, Halper J, Karpatkin H, Keller J, Ng AV, Pilutti LA, Rohrig A, Van Asch P, Zackowski K, Motl RW. Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Mult Scler. 2020 Oct;26(12):1459-1469. doi: 10.1177/1352458520915629. Epub 2020 Apr 23. PMID: 32323606 PubMed  
  34. Sandroff BM, Motl RW, Scudder MR, DeLuca J. Systematic, Evidence-Based Review of Exercise, Physical Activity, and Physical Fitness Effects on Cognition in Persons with Multiple Sclerosis. Neuropsychol Rev. 2016 Sep;26(3):271-294. doi: 10.1007/s11065-016-9324-2. Epub 2016 Jul 22. PMID: 27447980. PubMed  
  35. Kalron A, Zeilig G. Efficacy of exercise intervention programs on cognition in people suffering from multiple sclerosis, stroke and Parkinson's disease: A systematic review and meta-analysis of current evidence. NeuroRehabilitation. 2015;37(2):273-89. doi: 10.3233/NRE-151260. PMID: 26484519. PubMed  
  36. Motl RW, Sandroff BM, Kwakkel G, Dalgas U, Feinstein A, Heesen C, Feys P, Thompson AJ. Exercise in patients with multiple sclerosis. Lancet Neurol. 2017 Oct;16(10):848-856. doi: 10.1016/S1474-4422(17)30281-8. Epub 2017 Sep 12. PMID: 28920890. PubMed  
  37. Beckett JM, Bird ML, Pittaway JK, Ahuja KD. Diet and Multiple Sclerosis: Scoping Review of Web-Based Recommendations. Interact J Med Res. 2019 Jan 9;8(1):e10050. doi: 10.2196/10050. PMID: 30626570. PubMed  
  38. Wahls TL, Chenard CA, Snetselaar LG. Review of Two Popular Eating Plans within the Multiple Sclerosis Community: Low Saturated Fat and Modified Paleolithic. Nutrients. 2019 Feb 7;11(2):352. doi: 10.3390/nu11020352. PMID: 30736445. PubMed  
  39. SWANK RL. Treatment of multiple sclerosis with low-fat diet. AMA Arch Neurol Psychiatry. 1953 Jan;69(1):91-103. doi: 10.1001/archneurpsyc.1953.02320250097011. PMID: 12996138. PubMed  
  40. Tredinnick AR, Probst YC. Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review. Adv Nutr. 2020 Nov 16;11(6):1603-1615. doi: 10.1093/advances/nmaa063. PMID: 32504530. PubMed  
  41. Dworkin RH, Bates D, Millar JH, Paty DW. Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology. 1984 Nov;34(11):1441-5. doi: 10.1212/wnl.34.11.1441. PMID: 6387534. PubMed  
  42. Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Lilleås F, Pedersen T, Bjørnarå B, Dalene F, Kleveland G, Schepel J, Olsen IC, Myhr KM. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol. 2012 Aug;69(8):1044-51. doi: 10.1001/archneurol.2012.283. PMID: 22507886. PubMed  
  43. Pantzaris MC, Loukaides GN, Ntzani EE, Patrikios IS. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open. 2013 Apr 17;3(4):e002170. doi: 10.1136/bmjopen-2012-002170. PMID: 23599375. PubMed  
  44. Katz Sand I. The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence. Curr Nutr Rep. 2018 Sep;7(3):150-160. doi: 10.1007/s13668-018-0236-z. PMID: 30117071. PubMed  
  45. Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T. Impact of the environment on multiple sclerosis. Tidsskr Nor Laegeforen. 2015 May 19;135(9):856-60. English, Norwegian. doi: 10.4045/tidsskr.14.0751. PMID: 25991624. PubMed  
  46. Jouanguy E, Béziat V, Mogensen TH, Casanova JL, Tangye SG, Zhang SY. Human inborn errors of immunity to herpes viruses. Curr Opin Immunol. 2020 Feb;62:106-122. doi: 10.1016/j.coi.2020.01.004. Epub 2020 Jan 31. PMID: 32014647. PubMed  
  47. Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13. PMID: 35025605. PubMed  
  48. Bar-Or A, Pender MP, Khanna R, Steinman L, Hartung HP, Maniar T, Croze E, Aftab BT, Giovannoni G, Joshi MA. Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020). Trends Mol Med. 2021 Apr;27(4):410-411. doi: 10.1016/j.molmed.2021.01.004. Epub 2021 Feb 17. Erratum for: Trends Mol Med. 2020 Mar;26(3):296-310. PMID: 33608230. PubMed  
  49. Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017 Jan;13(1):25-36. doi: 10.1038/nrneurol.2016.187. Epub 2016 Dec 9. PMID: 27934854. PubMed  
  50. Olsson T. Epstein Barr virus infection and immune defense related to HLA-DR15: consequences for multiple sclerosis. Eur J Immunol. 2021 Jan;51(1):56-59. doi: 10.1002/eji.202049030. Epub 2020 Dec 22. PMID: 33350470. PubMed  
  51. Jacobs BM, Giovannoni G, Cuzick J, Dobson R. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors. Mult Scler. 2020 Oct;26(11):1281-1297. doi: 10.1177/1352458520907901. Epub 2020 Mar 23. PMID: 32202208. PubMed